C9orf72-related ALS
FTD-related C9orf72 hexanucleotide
pathogenic ALS
C9orf72 related disease
FTD Expansion
mouse models of C9orf72
patients
gene modification
Gene Editing
Therapeutic Strategy
successful CNS gene therapy
test gene therapy vectors
multiple sclerosis
Parkinson’s disease
therapeutic development
therapeutic targets
multiple disease scenarios amenable
treatment options
ultimate aim
ultimate benefit
amyotrophic lateral sclerosis
progressive motor deficits
lower motor neurons
common genetic cause
significant genetic discoveries
degeneration of upper
MNs
Huntington’s
non-coding region of chromosome
death
Alzheimer’s
open reading frame
similar approaches
CRISPR
Cas9 system
G4C2
neuromuscular respiratory failure
expansions
utmost importance
fatal condition
wide spectrum of neurodegenerative diseases
prospect
majority of afflicted individuals
cerebellar ataxias
frontotemporal dementia
economic burden of care
ERC Proof of Concept project
devastating disorders
research efforts
growing evidence
neurological conditions
years
field
Europe